Paulo Andrez is an angel investor and serial entrepreneur and the #1 bestselling author of Zero Risk Startup, published by Forbes Books. His track record includes an award for Best European Angel Investment in 2012 when United Resins reached 24.5 million euros in revenues in its first year, and an investment in Sword Health that became a unicorn in 2022. He played a key shareholder role in Novabase’s IPO on Euronext in 2000. Notable investments span Portugal, the USA, Estonia, Spain, Sweden and the UK and include United Resins, Thinkable, Climber, Sword Health, Novabase, Maven, Bugbox, Toys R US (PT & ES), New Atlantis, Spintop Ventures, Nascente Capital, Growth Partners Capital, E-Vittles, CoachVox and RideTandem.
A former President of EBAN, European Business Angel Network, he was appointed President Emeritus after serving until 2014. He founded the Entrepreneurship Agency DNA Cascais, which has supported more than 500 startups, and since 2012 has advised several European governments on early stage investment policy and business angels co‑investment fund design, including chairing a European Commission expert group for Slovakia and Romania. He is a frequent speaker and guest lecturer on innovation and early stage investment and has run workshops on new venture risk mitigation under the Zero Risk Startup programme since 2012.